CASE REPORT
Medical and psychological problems in diagnosing and treating a patient with chronic complex regional pain syndrome
Submission date: 2014-10-21
Final revision date: 2014-12-29
Acceptance date: 2015-01-26
Publication date: 2015-03-24
Medical Studies 2015;31(1):56-59
KEYWORDS
TOPICS
ABSTRACT
The aim of this study is to present the medical and psychological problems which occurred while diagnosing and treating a 42-year-old woman with complex regional pain syndrome (CRPS). It presents a description of somatic and emotional symptoms, social problems, and problems in diagnosis and treatment (left lower limb). Based on the described symptoms, it must be stated that there are specific premises to claim that the studied case fulfils the criteria of complex regional pain syndrome. Data concerning the patient’s psycho-emotional state were taken from a semi-structured interview, the degree of intensity of automatic negative thoughts, and psychological manifestations of hyperactivity by deep limbic system, developed by D. Amen. The patient had symptoms from a few categories, including sensation, reduced mobility, and trophic symptoms (skin lesions). Due to the complex nature of the formation of CRPS pain and associated disorders that are difficult to treat, multidisciplinary therapy was recommended.
REFERENCES (33)
2.
Potemski P, Polkowski W. Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych. Via Medica 2013; 125-35.
3.
Buas MF, Vaughan TL. Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol 2013; 23: 3-9.
5.
Olszewska M, Głuszek S. New possibilities for the treatment of gastric cancer. Studia Medyczne 2013; 29: 343-8.
6.
Park D, Yun JW, Park JH, et al. HER-2/neu amplification is an independent prognostic factor in gastric cancer. Dig Dis Sci 2006; 51: 1371-9.
7.
Bilici A. Treatment options in patients with metastatic gastric cancer: current status and future perspectives. World J Gastroenterol 2014; 20: 3905-15.
8.
Li LF, Wei ZJ, Sun H, et al. Abnormal beta-catenin immunohistochemical expression as a prognostic factor in gastric cancer: a meta-analysis. World J Gastroenterol 2014; 20: 12313-21.
9.
Scartozzi M, Galizia E, Freddari F, et al. Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches. Cancer Treat Rev 2004; 30: 451-9.
10.
Jørgensen JT. Role of human epidermal growth factor receptor 2 in gastric cancer: biological and pharmacological aspects. World J Gastroenterol 2014; 20: 4526-35.
11.
Jørgensen JT, Hersom M. HER2 as a prognostic marker in gastric cancer – a systematic analysis of data from the literature. J Cancer 2012; 3: 137-44.
12.
Ku GY, Ilson DH. Esophagogastric cancer: targeted agent. Cancer Treat Rev 2010; 36: 235-48.
13.
Wagner AD, Moehler M. Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era. Curr Opin Oncol 2009; 21: 381-5.
14.
Song ZJ, Gong P, Wu YE. Relationship between the expression of iNOS, VEGF, tumor angiogenesis and gastric cancer. World J Gastroenterol 2002; 8: 591-5.
15.
Cancer Genome Atlas Research Network: Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014; 513: 202-9.
16.
Basbaum AI, Bautista DM, Scherrer G, et al. Cellular and molecular mechanisms of pain. Cell 2009; 139: 267-84.
17.
Dobrogowski J, Zajączkowska R, Dutka J, Wordliczek J. Patofizjologia i klasyfikacja bólu. Pol Przegl Neurol 2011; 7: 20-30.
18.
Ortenburger D. Biopsychospołeczny model leczenia bólu. Gdy medycznym sposobom towarzyszy psychoterapia i pomoc psychologiczna. Ból 2011; 12: 13-22.
19.
Finniss DG, Kaptchuk TJ, Franklin Miller F, et al. Placebo effects: biological, clinical and ethical advances. Lancet 2010; 375: 686-95.
21.
Butera JA. Miniperspectives: recent approaches in the treatment of neuropathic pain. J Med Chem 2007; 11: 2543-6.
24.
Reinders MF, Geertzen JH, Dijkstra PU. Complex regional pain syndrome type I: use of the International Association for the Study of Pain diagnostic criteria defined in 1994. Clin J Pain 2002; 18: 207-15.
25.
v Danis D, Mikuła W. Algodystrofia pourazowa w obrębie kończyny dolnej po złamaniu kostek goleni. Medycyna Rodzinna 2002; 5: 191-3.
26.
Hsu ES. Practical management of complex regional pain syndrome. Am J Ther 2009; 16: 147-54.
27.
Harden RN, Bruehl S, Perez RS, et al. Validation of proposed diagnostic criteria (the Budapest Criteria) for Complex Regional Pain Syndrome. Pain 2010; 150: 268-74.
28.
Hogan CJ, Hurwitz SR. Treatment of complex regional pain syndrome of the lower extremity. J Am Acad Orthop Surg 2002; 10: 281-9.
29.
Żyluk A, Puchalski P. Wczesne rozpoznanie pourazowej algodystrofii. Chir Narz Ruchu Ort Pol 2003; 68: 109-13.
30.
Moseley GL, Gallace A, Spence C. Is mirror therapy all it is cracked up to be? Current evidence and future directions. Pain 2008; 138: 7-10.
31.
Moseley GL, Gallace A, Spence C. Mirror therapy for chronic complex regional pain syndrome type 1 and stroke. N Engl J Med 2009; 361: 634-6.
32.
Ccahio A, De Blasis E, Necozione S, et al. Mirror therapy for chronic complex regional pain syndrom type 1 and stroke. N Engl J Med 2009; 361: 634-6.
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
